#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	18140	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2134	840.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1512	1512	C	1037	C,T,G	1007,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33918	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3474	967.6	0	.	n	.	0	T695C	SNP	695	695	T	1023	1023	C	1069	C	1037	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33918	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3474	967.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1665	1665	A	1110	A	1071	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33918	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3474	967.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2299	2299	C	1028	C	990	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33918	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3474	967.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2373	2373	A	1051	A	1020	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33918	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3474	967.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2925	2925	C	1051	C	1023	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33918	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3474	967.6	0	HET	.	.	.	A790G	.	790	790	A	1118	1118	A	1039	A,G	552,455	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2242	folP	855	855	100.0	folP.l15.c4.ctg.1	1480	149.9	1	SNP	p	R229S	0	.	.	685	687	CGC	971	973	CGC	237;239;243	C;G;C	229;231;235	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6248	gyrA	2751	2751	99.89	gyrA.l6.c17.ctg.1	3488	177.8	1	SNP	p	S91F	0	.	.	271	273	TCC	668	670	TCC	227;228;228	T;C;C	217;220;221	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6248	gyrA	2751	2751	99.89	gyrA.l6.c17.ctg.1	3488	177.8	1	SNP	p	D95N	0	.	.	283	285	GAC	680	682	GAC	211;211;209	G;A;C	199;197;199	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6248	gyrA	2751	2751	99.89	gyrA.l6.c17.ctg.1	3488	177.8	1	SNP	p	D95G	0	.	.	283	285	GAC	680	682	GAC	211;211;209	G;A;C	199;197;199	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1998	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1256	157.2	1	SNP	p	G45D	1	.	.	133	135	GAC	411	413	GAC	235;239;239	G;A;C	230;225;233	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1022	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1118	91.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5942	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3030	194.3	1	SNP	p	D86N	0	.	.	256	258	GAC	601	603	GAC	234;234;235	G;A;C	225;221;226	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5942	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3030	194.3	1	SNP	p	S88P	0	.	.	262	264	TCC	607	609	TCC	231;228;232	T;C;C	218;217;220	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4686	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2570	180.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1477	1479	GGC	217;209;208	G,A;G;C	209,1;204;200	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	A502V	1	A502V	NONSYN	1504	1506	GCG	1783	1785	GTG	188;187;191	G;T,G;G	178;152,9;183	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1210	1212	GCA	275;277;279	G,T;C,A;A	264,1;258,1;273	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1213	1215	ATC	283;285;289	A;T;C	272;276;279	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1225	1227	GTG	290;288;291	G;T;G	278;276;281	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1225	1227	GTG	290;288;291	G;T;G	278;276;281	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1729	1731	ACC	192;192;191	A;C;C	176;183;187	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1906	1908	GGC	179;178;178	G;G;C	173;171;170	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1915	1917	GGC	163;162;163	G;G;C	156;155;155	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4842	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2272	210.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1933	1935	CTG	152;154;150	C,G;T,G;G,T,C	128,12;126,1;130,1,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6944	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	2941	233.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1507	1509	CCG	260;260;262	C;C;G	240;252;243	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2598	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1718	149.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	339	341	GGC	188;188;188	G,A;G,A;C	182,2;180,1;178	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2598	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1718	149.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	521	521	C	166	C	162	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3692	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1536	237.9	0	.	p	.	0	G120N	NONSYN	358	360	GGC	680	682	AAC	290;289;291	A;A;C,G	279;279;280,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3692	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1536	237.9	0	.	p	.	0	E212G	NONSYN	634	636	GAA	956	958	GGA	306;307;303	G;G;A	299;300;290	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3692	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1536	237.9	0	.	p	.	0	Y216_S217del	DEL	646	646	T	968	968	T	304	T	293	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3692	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1536	237.9	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1196	1198	AAT	324;325;320	A,G,T,C;A;T	312,1,1,1;318;310	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3692	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1536	237.9	1	SNP	p	D121N	0	.	.	361	363	GAC	683	685	GAC	300;299;300	G,T;A;C	288,1;289;293	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3692	porB1b	1047	1047	99.04	porB1b.l6.c30.ctg.1	1536	237.9	1	SNP	p	A121D	1	.	.	361	363	GAC	683	685	GAC	300;299;300	G,T;A;C	288,1;289;293	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12956	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4784	268.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1476	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	902	160.7	1	SNP	p	V57M	1	.	.	169	171	ATG	421	423	ATG	304;303;301	A,C;T;G	289,1;291;290	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
